Learning Objectives:
After completing this activity, the learner will be able to:
- Discuss strategies for the pharmacologic management of patients with major depressive disorder beyond the first antidepressant trial.
- Compare switching and augmentation as strategies for the management of major depressive disorder.
- Identify useful treatment combinations for depressed patients who manifest with specific symptom clusters, such as anxious distress, psychotic features, and poor focus.
Original Release Date: 12/01/2020
Review and Re-release Date: 03/01/2023
Expiration Date: 04/01/2023
Relevant Financial Disclosures:
The following planners, faculty, and reviewers have the following relevant financial relationships with commercial interests to disclose:
Dr. Thase has disclosed the following relationships:
- Acadia, Akili, Alkermes, Allergan, Clexio, Gerson Lehrman Group, Guidepoint Global, Janssen Pharmaceuticals, Jazz Pharmaceuticals, H. Lundbeck A/S, Otsuka Pharmaceutical Co., Pfizer, Sage Pharmaceuticals, Sunovion Pharmaceuticals, Takeda Pharmaceutical Co: consulting
- Acadia, Inc., Alkermes, Allergan, Axsome, Inc., Intracellular Inc., Janssen Pharmaceuticals, Inc., Myriad (AssureRx), National Institute of Mental Health, Patient Centered Outcomes Research Institute: contracted research
- American Psychiatric Foundation, Guilford Publications, Herald House, W.W. Norton & Company, Inc., Wolters Kluwer Health.: Other
- Peloton Advantage: Senior Medical Director
All of the relevant financial relationships listed for these individuals have been mitigated.
Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com
Instructions for Participation and Credit:
Participants must complete the activity online during the valid credit period that is noted above.
Follow these steps to earn CME credit:
- View the required educational content provided on this course page.
- Answer the quiz for promoting retention of knowledge.
- Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
- Download your certificate.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Medical Academy designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
